The two major genotypic markers that distinguish community acquired (CA) from hospital acquired (HA) methicillin resistant staphylococcus aureus (MRSA) isolates are the architecture of mobile genetic element (SCCmec type) and presence of panton valentine leukocidin (PVL) toxin. This study was conducted to determine the molecular characteristics of CA-and HA-MRSA and methicillin sensitive s. aureus (MSSA) isolates in Sikkim.
The architecture of staphylococcal cassette chromosome mec (SCCmec) type and presence of panton valentine leukocidin (PVL) toxin are the two important genotypic markers that differentiate communityacquired methicillin-resistant Staphylococcus aureus (CA-MRSA) strains from hospital-acquired (HA)-MRSA 1 . Based on SCCmec types, HA-MRSA usually carried large SCCmec element; typess I, 2 but CA-MRSA harboured newly described smaller SCCmec element type IV (24kb) 3 or less frequently V or a variant V T 4 . The PVL toxin is widely associated with the presence of SCCmec types IV and sporadically with SCCmec type V or V T but not with SCCmec type, I, II or III 1 . High association of PVL toxin in CA-MRSA strains is thought to have evolved via methicillin-sensitive S. aureus (MSSA) strains acquiring the lukS-PV and lukF-PV genes for PVL production and the resulting PVL positive MSSA gaining methicillin resistance through integration of the smaller, more mobile SCCmec types IV or V 1 .
The present study was undertaken to compare the molecular characteristics of community-and hospitalacquired MRSA and MSSA isolates in Sikkim by detecting two major genotypic markers; presence of pvl gene and SCCmec type, and to determine the diversity of SCCmec type of MRSA strains circulating in this region.
Material & Methods

Settings and bacterial isolates:
A total of 150 S. aureus isolates obtained from the various clinical specimens of blood (10), sputum (1), throat swab (1) and pus (138) submitted to the department of Microbiology of Sikkim Manipal Institute of Medical Sciences (SMIMS) and Sir Thutob Namgyal Memorial (STNM) hospital at Gangtok, Sikkim, during the period from September 2009 to March 2011, were studied. The study was approved by the ethics committee of SMIMS.
Confirmation and storage of S. aureus isolates:
All these isolates were confirmed as S. aureus by using standard techniques
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. The isolates were inoculated into the semi-solid nutrient agar and stored at -20ºC until further study.
Case definition : HA-MRSA was defined as one cultured from a clinical specimen obtained ≥72 h after patient's hospital admission or whose sources of isolation were associated with risk factors for HA-MRSA infection (e.g. recent hospitalization, recent surgery, residence in a long-term care facility, drug use) 6 , within one year of MRSA isolation date. CA-MRSA isolate was defined as one cultured < 72 h of a patient's hospital admission, or whose sources of isolation were not associated with risk factors for HA-MRSA infection. In a similar manner HA-and CA-MSSA were defined 8 .
Exclusion criteria: Duplicate isolates from the same patients, even if the site of infection was different during the sample collection time frame were excluded from the study. , respectively. Primers were blasted and commercially obtained from Sigma-Aldrich Pvt. Ltd., Bangalore. PCR was performed by using Multiplex PCR kit (Qiagen, Hilden, Germany) with slight modification of final reaction volume of 25 μl (12.5 µl mastermix, 2.5 µl primer mix, 3µl of DNA template and 7µl of RNase-free water). Thermocycling conditions and visualization of products were done as per the manufacturer's instructions. Reference strains ATCC 43300 and 25923 were used as positive and negative controls for mec-A gene, respectively and ATCC 43300 was used as negative control for pvl gene.
DNA isolation:
Multiplex PCR:
Primers -Primers were selected from the published sequence of the SCCmec types I-III (Oliveria et al) 7 , IVa -IVb (Okuma et al) 9 , IVc-IVd (Hisata et al)
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, V (Zang et al) 11 and were commercially obtained from Sigma-Aldrich Pvt., Ltd., Bengaluru.
Preparation of primer mix -The preparation of primer mix was done as per manufacturer's instructions of multiplex PCR kit (Qiagen). For multiplex PCR, the primers were divided into two sets: set A was designed to amplify SCCmec type I, II, III, V and mec-A, whereas set B was designed to amplify SCCmec IVa, IVb, IVc, IVd and mec-A. The mec-A gene was included in the protocol as an internal positive control.
SCCmec typing -To ensure the individual primer pairs were adequate for the amplification of all loci (gene fragments), the single-target PCR protocol 11 with each individual primer pair was conducted prior to the multiplex PCR optimization. Then PCR was performed by using Qiagen Multiplex PCR kit with slight INDIAN J MeD ReS, SePTeMBeR 2015 modification. Reaction was run in two sets with two different sets of primers mix. Multiplex PCR with set A primers consisting of 12.5 µl mastermix, 2.5 µl primer mix (set A), 3µl of DNA template and 7µl of RNasefree water with total reaction volume of 25µl. Multiplex primer set B included the same constituents as in set A except for the primers mix (set B). Thermocycling conditions and visualization of products were done as per the manufacturer's instructions.
Antibiotic susceptibility testing of MRSA isolatesKirby-Bauer disc diffusion method 12 was performed with following antibiotics discs (Hi-Media, Mumbai); penicillin-G (10 units), co-trimoxazole (25 µg), erythromycin (15 µg), ofloxacin (5 µg), gentamicin (10 µg), linezolid (30 µg/ml), rifampicin (5 µg), chloramphenicol (30 µg), fusidic acid (30 µg). Five discs in one and four in another agar plate were tested. The testing conditions and interpretation of the test was done as per Clinical and Laboratory Standards Institute (CLSI) criteria 13 . MRSA isolates resistant to ≥ three non-beta lactam antibiotics were classified as multidrug-resistant MRSA (MDR-MRSA) 14 .
Statistical analysis: Categorical variables were analyzed using Chi-square and Fisher's exact tests using IBM SPSS Statistics 20 (IBM Corporation, uSA).
The ethical clearance was taken from the Institutional ethics committee, SMIMS.
Results
Duplex PCR: Out of 150 S. aureus isolates, 53 (35.33%) and 66 (44%) showed amplifications with mec-A and pvl genes, respectively (Fig. 1) . Among 150 S. aureus isolates, 38 (25.33%) met the definition of CA-MRSA and 15 (10%) of HA-MRSA and rest of CA-MSSA and HA-MSSA (Table I ). All MRSA isolates were positive for pvl barring two HA-MRSA isolates. Among MSSA, 12.37 per cent (12/97) and 3.09 per cent (3/97) were pvl positive CA-MSSA and pvl positive HA-MSSA, respectively. The presence of PVL toxin was significantly higher (P<0.001) in overall MRSA population (77.27% or 51/66) than that in MSSA (22.72% or 15/66).
SCCmec typing: SCCmec typing patterns of MRSA isolates (Figs 2 and 3) , and its distribution in two groups of MRSA (CA-and HA-MRSA) is shown in Table II . All MRSA isolates tested were found to be positive for internal control (mec-A) included in every batch of testing. The SCCmec types distributions in HA-MRSA patients were as follows: (i) patients developed infections ≥ 72 h of hospital admission (n=3), one each type I, II and II+III (ii) patients with previous history of hospital admission (n=9), one each type III, IVa, V, II+III, non-typeable and four isolates harboured combination band of III+V (iii) patients with previous history of antibiotic intake (n=3), III+V (two) and nontypeable (one).
Antimicrobial susceptibility pattern of MRSA isolates:
The results of in vitro susceptibility testing of CAand HA-MRSA isolates are given in Table III . High percentage of CA-MRSA (92.10%) and all isolates of HA-MRSA were resistant to penicillin and cotrimoxazole. Among CA-and HA-MRSA, 18.42 per cent (7/38) and 46.66 per cent (7/15) were found to be multi-drug resistant (MDR), respectively. SCCmec types of MDR-HA-MRSA isolates were as follows: type I (one), III (two), V (one), II+III (one) and III +V (two). Similarly, SCCmec types of MDR-CA-MRSA were type V (two), II+III (one), II+V (two) and III+V (two). SCCmec type III has been reported to be the predominant MRSA in Asian continent except Korea and Japan 22, 25 . The present study showed low occurrence of type III MRSA isolates in Sikkim (3.8%) compared to that reported from other parts of India 22, [25] [26] [27] . D'Souza et al 16 from Mumbai, India, reported that SCCmec type V (41.01%) was higher than type III (24.55%). Our study suggests that SCCmec type V seems to be an emerging MRSA in this part of India.
In our study only one HA-MRSA isolate was found to be positive for type IVa. On the contrary, a study from Mumbai, India, reported presence of SCCmec type IV in 34 per cent of MRSA isolates collected during a three year period. In earlier studies 24,27 conducted on the MRSA isolates collected from Indian hospitals have not reported type IV MRSA isolates.
The association of specific SCCmec type in CAand HA-MRSA isolates has been well characterized, and formed the basis of molecular definition 1 . In the present study, the SCCmec types IV and V which are typically associated with CA-MRSA, were also found in HA-MRSA isolates. Yu et al 28 reported type IV in HA-MRSA isolates (12.5%). Gonzalez et al 29 also reported CA-MRSA isolates (SCCmec type IV) as an important cause of healthcare-associated infections. This indicates that HA-MRSA with typical molecular characteristics of CA-MRSA (SCCmec type IVa, V 
Discussion
In the present study, we evaluated the presence of PVL toxin as a marker of CA-MRSA isolates. .5 per cent of HA-MRSA as MDR, whereas no MDR was found among the CA-MRSA isolates. In our study also, occurrence of MDR-MRSA was more in HA-MRSA than CA-MRSA.
In conclusion, pvl may no longer be a reliable marker for CA-MRSA isolates, rather all MRSA may be important reservoir of PVL toxin, and SCCmec type V MRSA is emerging as predominant isolates over most prevalent type III/IIIA. Multidrug resistance seen among CA-MRSA indicates the changing epidemiological and microbiological characteristics of MRSA in the community and hospitals in this part of India.
